BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lei Y, Tang R, Xu J, Wang W, Zhang B, Liu J, Yu X, Shi S. Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol 2021;14:91. [PMID: 34108022 DOI: 10.1186/s13045-021-01105-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu L, Zou C, Zhang S, Chu TSM, Zhang Y, Chen W, Zhao C, Yang L, Xu Z, Dong S, Yu H, Li B, Guan X, Hou Y, Kong FM. Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors. J Hematol Oncol 2022;15:87. [PMID: 35799264 DOI: 10.1186/s13045-022-01307-2] [Reference Citation Analysis]
2 Dorado G, Gálvez S, Rosales TE, Vásquez VF, Hernández P. Analyzing Modern Biomolecules: The Revolution of Nucleic-Acid Sequencing - Review. Biomolecules 2021;11:1111. [PMID: 34439777 DOI: 10.3390/biom11081111] [Reference Citation Analysis]
3 Alpár D, Egyed B, Bödör C, Kovács GT. Single-Cell Sequencing: Biological Insight and Potential Clinical Implications in Pediatric Leukemia. Cancers (Basel) 2021;13:5658. [PMID: 34830811 DOI: 10.3390/cancers13225658] [Reference Citation Analysis]
4 Redavid I, Conserva MR, Anelli L, Zagaria A, Specchia G, Musto P, Albano F. Single-Cell Sequencing: Ariadne’s Thread in the Maze of Acute Myeloid Leukemia. Diagnostics 2022;12:996. [DOI: 10.3390/diagnostics12040996] [Reference Citation Analysis]
5 Hussen BM, Abdullah ST, Salihi A, Sabir DK, Sidiq KR, Rasul MF, Hidayat HJ, Ghafouri-Fard S, Taheri M, Jamali E. The emerging roles of NGS in clinical oncology and personalized medicine. Pathol Res Pract 2022;230:153760. [PMID: 35033746 DOI: 10.1016/j.prp.2022.153760] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hoft SG, Pherson MD, DiPaolo RJ. Discovering Immune-Mediated Mechanisms of Gastric Carcinogenesis Through Single-Cell RNA Sequencing. Front Immunol 2022;13:902017. [PMID: 35757757 DOI: 10.3389/fimmu.2022.902017] [Reference Citation Analysis]
7 Li Q, Zhang X, Ke R. Spatial Transcriptomics for Tumor Heterogeneity Analysis. Front Genet 2022;13:906158. [DOI: 10.3389/fgene.2022.906158] [Reference Citation Analysis]
8 Shi T, Xie M, Chen L, Yuan W, Wang Y, Huang X, Xie W, Meng H, Lou Y, Yu W, Tong H, Ye X, Huang J, Jin J, Zhu H. Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era. Exp Hematol Oncol 2022;11:13. [PMID: 35277197 DOI: 10.1186/s40164-022-00265-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sreenivasan VKA, Balachandran S, Spielmann M. The role of single-cell genomics in human genetics. J Med Genet 2022:jmedgenet-2022-108588. [PMID: 35790352 DOI: 10.1136/jmedgenet-2022-108588] [Reference Citation Analysis]
10 Huang L, Yi X, Yu X, Wang Y, Zhang C, Qin L, Guo D, Zhou S, Zhang G, Deng Y, Bao X, Wang D. High-Throughput Strategies for the Discovery of Anticancer Drugs by Targeting Transcriptional Reprogramming. Front Oncol 2021;11:762023. [PMID: 34660328 DOI: 10.3389/fonc.2021.762023] [Reference Citation Analysis]
11 Chen Y, Zhang Z, Yang X, Liu A, Liu S, Feng J, Xuan K. Odontogenic MSC Heterogeneity: Challenges and Opportunities for Regenerative Medicine. Front Physiol 2022;13:827470. [PMID: 35514352 DOI: 10.3389/fphys.2022.827470] [Reference Citation Analysis]
12 Casado-Pelaez M, Bueno-Costa A, Esteller M. Single cell cancer epigenetics. Trends Cancer 2022:S2405-8033(22)00133-9. [PMID: 35821003 DOI: 10.1016/j.trecan.2022.06.005] [Reference Citation Analysis]
13 Pan D, Jia D. Application of Single-Cell Multi-Omics in Dissecting Cancer Cell Plasticity and Tumor Heterogeneity. Front Mol Biosci 2021;8:757024. [PMID: 34722635 DOI: 10.3389/fmolb.2021.757024] [Reference Citation Analysis]
14 Li Y, Wang J, Wang H, Zhang S, Wei Y, Liu S. The Interplay Between Inflammation and Stromal Components in Pancreatic Cancer. Front Immunol 2022;13:850093. [DOI: 10.3389/fimmu.2022.850093] [Reference Citation Analysis]
15 Lavallee E, Sfakianos JP, Mulholland DJ. Tumor Heterogeneity and Consequences for Bladder Cancer Treatment. Cancers (Basel) 2021;13:5297. [PMID: 34771460 DOI: 10.3390/cancers13215297] [Reference Citation Analysis]
16 Sun Y, Jiang L, Wen T, Guo X, Shao X, Qu H, Chen X, Song Y, Wang F, Qu X, Li Z. Trends in the Research Into Immune Checkpoint Blockade by Anti-PD1/PDL1 Antibodies in Cancer Immunotherapy: A Bibliometric Study. Front Pharmacol 2021;12:670900. [PMID: 34489691 DOI: 10.3389/fphar.2021.670900] [Reference Citation Analysis]
17 Bleve A, Consonni FM, Porta C, Garlatti V, Sica A. Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective. Cancers (Basel) 2022;14:510. [PMID: 35158779 DOI: 10.3390/cancers14030510] [Reference Citation Analysis]
18 Liu SQ, Gao ZJ, Wu J, Zheng HM, Li B, Sun S, Meng XY, Wu Q. Single-cell and spatially resolved analysis uncovers cell heterogeneity of breast cancer. J Hematol Oncol 2022;15:19. [PMID: 35241110 DOI: 10.1186/s13045-022-01236-0] [Reference Citation Analysis]
19 Arias-Hidalgo C, Juanes-Velasco P, Landeira-Viñuela A, García-Vaquero ML, Montalvillo E, Góngora R, Hernández ÁP, Fuentes M. Single-Cell Proteomics: The Critical Role of Nanotechnology. Int J Mol Sci 2022;23:6707. [PMID: 35743151 DOI: 10.3390/ijms23126707] [Reference Citation Analysis]